Learn More
Selleck Chemical LLC Ipilimumab (anti-CTLA-4) 1mg 477202-00-9 MDX-010, BMS-734016, Yervoy

Supplier: Selleck Chemical LLC A20011MG

Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor. MW : 148 kD. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.